Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

121 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Alzheimer's Biomarker Consortium-Down Syndrome: Rationale and methodology.
Handen BL, Lott IT, Christian BT, Schupf N, OBryant S, Mapstone M, Fagan AM, Lee JH, Tudorascu D, Wang MC, Head E, Klunk W, Ances B, Lai F, Zaman S, Krinsky-McHale S, Brickman AM, Rosas HD, Cohen A, Andrews H, Hartley S, Silverman W; Alzheimer's Biomarker Consortium‐Down Syndrome (ABC‐DS). Handen BL, et al. Among authors: mapstone m. Alzheimers Dement (Amst). 2020 Aug 3;12(1):e12065. doi: 10.1002/dad2.12065. eCollection 2020. Alzheimers Dement (Amst). 2020. PMID: 32775597 Free PMC article. Review.
Predictors of Cognitive Change in Parkinson Disease: A 2-year Follow-up Study.
Gasca-Salas C, Duff-Canning S, McArthur E, Armstrong MJ, Fox S, Meaney CA, Tang-Wai DF, Gill D, Eslinger PJ, Zadikoff C, Marshall FJ, Mapstone M, Chou KL, Persad C, Litvan I, Mast BT, Gerstenecker AT, Weintraub S, Marras C. Gasca-Salas C, et al. Among authors: mapstone m. Alzheimer Dis Assoc Disord. 2023 Oct-Dec 01;37(4):335-342. doi: 10.1097/WAD.0000000000000576. Epub 2023 Aug 22. Alzheimer Dis Assoc Disord. 2023. PMID: 37615480
Temporospatial components of brain ERPs as biomarkers for Alzheimer's disease.
Chapman RM, Gardner MN, Klorman R, Mapstone M, Porsteinsson AP, Antonsdottir IM, Kamalyan L. Chapman RM, et al. Among authors: mapstone m. Alzheimers Dement (Amst). 2018 Aug 30;10:604-614. doi: 10.1016/j.dadm.2018.08.002. eCollection 2018. Alzheimers Dement (Amst). 2018. PMID: 30417070 Free PMC article.
Metabolic correlates of prevalent mild cognitive impairment and Alzheimer's disease in adults with Down syndrome.
Mapstone M, Gross TJ, Macciardi F, Cheema AK, Petersen M, Head E, Handen BL, Klunk WE, Christian BT, Silverman W, Lott IT, Schupf N; Alzheimer's Biomarkers Consortium–Down Syndrome (ABC‐DS) Investigators. Mapstone M, et al. Alzheimers Dement (Amst). 2020 Apr 5;12(1):e12028. doi: 10.1002/dad2.12028. eCollection 2020. Alzheimers Dement (Amst). 2020. PMID: 32258359 Free PMC article.
Proteomic profiles for Alzheimer's disease and mild cognitive impairment among adults with Down syndrome spanning serum and plasma: An Alzheimer's Biomarker Consortium-Down Syndrome (ABC-DS) study.
Petersen ME, Zhang F, Schupf N, Krinsky-McHale SJ, Hall J, Mapstone M, Cheema A, Silverman W, Lott I, Rafii MS, Handen B, Klunk W, Head E, Christian B, Foroud T, Lai F, Rosas HD, Zaman S, Ances BM, Wang MC, Tycko B, Lee JH, O'Bryant S; Alzheimer's Biomarker Consortium – Down Syndrome (ABC‐DS). Petersen ME, et al. Among authors: mapstone m. Alzheimers Dement (Amst). 2020 Jun 30;12(1):e12039. doi: 10.1002/dad2.12039. eCollection 2020. Alzheimers Dement (Amst). 2020. PMID: 32626817 Free PMC article.
The AT(N) framework for Alzheimer's disease in adults with Down syndrome.
Rafii MS, Ances BM, Schupf N, Krinsky-McHale SJ, Mapstone M, Silverman W, Lott I, Klunk W, Head E, Christian B, Lai F, Rosas HD, Zaman S, Petersen ME, Strydom A, Fortea J, Handen B, O'Bryant S. Rafii MS, et al. Among authors: mapstone m. Alzheimers Dement (Amst). 2020 Oct 27;12(1):e12062. doi: 10.1002/dad2.12062. eCollection 2020. Alzheimers Dement (Amst). 2020. PMID: 33134477 Free PMC article.
Plasma Total-Tau and Neurofilament Light Chain as Diagnostic Biomarkers of Alzheimer's Disease Dementia and Mild Cognitive Impairment in Adults with Down Syndrome.
Petersen ME, Rafii MS, Zhang F, Hall J, Julovich D, Ances BM, Schupf N, Krinsky-McHale SJ, Mapstone M, Silverman W, Lott I, Klunk W, Head E, Christian B, Foroud T, Lai F, Diana Rosas H, Zaman S, Wang MC, Tycko B, Lee JH, Handen B, Hartley S, Fortea J, O'Bryant S; Alzheimer’s Biomarker Consortium –Down Syndrome (ABC-DS). Petersen ME, et al. Among authors: mapstone m. J Alzheimers Dis. 2021;79(2):671-681. doi: 10.3233/JAD-201167. J Alzheimers Dis. 2021. PMID: 33337378 Free PMC article.
A blood screening tool for detecting mild cognitive impairment and Alzheimer's disease among community-dwelling Mexican Americans and non-Hispanic Whites: A method for increasing representation of diverse populations in clinical research.
O'Bryant SE, Zhang F, Petersen M, Hall JR, Johnson LA, Yaffe K, Mason D, Braskie M, Barber RA, Rissman RA, Mapstone M, Mielke MM, Toga AW; HABLE Study Team. O'Bryant SE, et al. Among authors: mapstone m. Alzheimers Dement. 2022 Jan;18(1):77-87. doi: 10.1002/alz.12382. Epub 2021 May 31. Alzheimers Dement. 2022. PMID: 34057802 Free PMC article.
Impact of the COVID-19 pandemic on daily life, mood, and behavior of adults with Down syndrome.
Hartley SL, Fleming V, Piro-Gambetti B, Cohen A, Ances BM, Yassa MA, Brickman AM, Handen BL, Head E, Mapstone M, Christian BT, Lott IT, Doran E, Zaman S, Krinsky-McHale S, Schmitt FA, Hom C, Schupf N; ABC-DS Group. Hartley SL, et al. Among authors: mapstone m. Disabil Health J. 2022 Jul;15(3):101278. doi: 10.1016/j.dhjo.2022.101278. Epub 2022 Feb 17. Disabil Health J. 2022. PMID: 35256308 Free PMC article.
121 results